Colin Barker, MD, a national leader in percutaneous heart valve therapies, has joined Vanderbilt University Medical Center as the new director of Interventional Cardiology. He began seeing patients July 2.

Vanderbilt Heart and Vascular Institute is now offering a new procedure that reduces stroke risk for many high-risk patients during interventions for extracranial carotid disease

For the first time in 27 years, Jerry Flowers is looking at life without using blood thinners, thanks to a small device that was implanted in his heart in a clinical trial at Vanderbilt Heart and Vascular Institute (VHVI).

Matthew Bacchetta, MD, MBA, MA, has joined the Department of Thoracic Surgery as an associate professor and the surgical director of a new respiratory institute at Vanderbilt University Medical Center that will be launched soon.

Marshall H. Crenshaw, MD, assistant professor of Medicine in the Division of Cardiology, died Aug. 23. He was 62.

Experts at the Vanderbilt Heart and Vascular Institute are forging new ground in the development of a first-of-its-kind program aimed at adults with congenital heart disease (ACHD).

Since launching its program offering patients with non-valvular atrial fibrillation (AF) an alternative treatment to reduce their risk of stroke and avoiding long-term use of blood thinners, the Vanderbilt Heart and Vascular Institute (VHVI) has consistently ranked among the top centers in the country for the implantation of left atrial appendage closure (LAAC) devices.